Recruiting for Oncology Trials in Eastern Europe

Only 3% of eligible cancer patients participating in clinical trials worldwide. Women are even less likely to participate. For those of us working in clinical research, it's time to reflect on the ways to advance women's health around the globe and improve those numbers.

Previously, we have discussed why outsourcing to a local CRO is a smart choice for study sponsors (and large CROs, as well). The patient recruitment benefits alone are compelling enough to draw trials to specific areas around the globe with strong track records of clinical trial success. In this article, we will narrow in on - Eastern Europe and its benefits for oncology trials. Read the full article on our blog. Back to the list